AI Engines For more Details: Perplexityβ Kagi Labsβ Youβ
Acne: Minocycline is commonly prescribed for the treatment of acne vulgaris, a common skin condition characterized by the formation of pimples, blackheads, and whiteheads. It works by reducing inflammation and killing acne-causing bacteria on the skin.
Rosacea: Minocycline may also be used to treat rosacea, a chronic skin condition characterized by facial redness, flushing, and the presence of papules and pustules. It can help reduce inflammation and control the symptoms of rosacea.
Respiratory Tract Infections: Minocycline may be used to treat respiratory tract infections caused by susceptible bacteria, including:
Urinary Tract Infections (UTIs): Minocycline may be effective against certain urinary tract infections caused by susceptible bacteria, such as Escherichia coli.
Sexually Transmitted Infections (STIs): Minocycline may be used to treat certain sexually transmitted infections, including:
Periodontal Disease: Minocycline may be used as an adjunctive treatment for periodontal disease (gum disease) in combination with scaling and root planing procedures. It can help reduce inflammation and bacterial growth in the gums.
Other Infections: Minocycline may be prescribed for various other bacterial infections, including skin infections, cellulitis, infected wounds, and certain types of bacterial meningitis.
Lyme Disease: Minocycline may be used as part of the treatment regimen for early localized or early disseminated Lyme disease caused by Borrelia burgdorferi bacteria.
Safety Considerations: Common side effects of minocycline may include nausea, vomiting, diarrhea, dizziness, and skin sensitivity to sunlight. Long-term use of minocycline may also be associated with rare but serious adverse effects, such as drug-induced lupus-like syndrome, autoimmune hepatitis, and intracranial hypertension.
Drug Interactions: Minocycline may interact with certain medications, including antacids containing aluminum, calcium, or magnesium, oral contraceptives, and blood-thinning medications like warfarin. It is important to inform healthcare providers about all medications being taken to avoid potential interactions.
(acneclin, bagomicina, borymycin, clinax, cyclimycin, cynomycin, dacnel, drenix, minima, minociclina genfar, minociclina richet, minocin, minocyclin rth, minosine, minot, seboclear, skid, aknemin, aknosan, apo-minocycline, arestin, cipancin, cleervue-m, cyclin, cycline, delnil, dexcel acnamino mr, dynacin, haicin, kang ni, klinotab, mei nong, mei nuo xing, meibi, meikewei, melicin, micromycin, minac, minakne, minaxen, mino, mino-50, minocin akne, minocin mr, minoclin, minoclir, minocyclin hexal, minocyclin-ct, minocycline actavis, minocycline aurobindo, minocycline biogaran, minocycline ccpc, minocycline dental dong kook, minocycline disphar, minocycline eg, minocycline eurogenerics, minocycline hydrochloride 2% sawai, minocycline hydrochloride actavis, minocycline hydrochloride f, minocycline hydrochloride nichi-iko, minocycline hydrochloride sawai, minocycline hydrochloride taiyo, minocycline hydrochloride towa, minocycline kojar, minocycline mylan, minocycline panbiotic, minocycline pch, minocycline root, minocycline sandoz, minocycline sanis health, minocycline-baiyunshan pharm, minocyclin-ratiopharm, minoderm, minogran, minoine, minoline, minomycin, minomycin 2%, minopac, minopen, minopen 2%, minostad, minotab, minotabs, minotek, minotowa, minotrex, minoz mr, mirosin, mynocine, myrac, namimycin, nocigen, nomika, parocline 2%, periocline, periofeel 2%, pms-minocycline, riva-minocycline, sandoz minocycline, solodyn, teva-minocycline, udima, uminon, ximino)
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
genus | Pediococcus | Reduces |
order | Micrococcales | Increases |
species | Acinetobacter calcoaceticus | Reduces |
species | Akkermansia muciniphila | Increases |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium longum | Reduces |
species | Blautia hansenii | Increases |
species | Blautia wexlerae | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
Taxonomy | Rank | Effect | Citations | Notation |
---|---|---|---|---|
[Butyribacterium] methylotrophicum | species | Decreases | πΆ Source Study | |
[Flavobacterium] lutescens | species | Decreases | πΆ Source Study | |
[Flavobacterium] lutescens | species | Decreases | πΆ Source Study | |
[Flavobacterium] lutescens | species | Decreases | πΆ Source Study | |
[Haemophilus] ducreyi | species | Decreases | πΆ Source Study | Chancroid |
[Haemophilus] ducreyi | species | Decreases | πΆ Source Study | Chancroid |
[Pseudomonas] hibiscicola | species | Decreases | πΆ Source Study | |
[Ruminococcus] torques | species | Decreases | π Source Study | |
[Ruminococcus] torques | species | Increases | πΆ Source Study | |
Abyssicoccus | genus | Decreases | πΆ Source Study | |
Abyssicoccus | genus | Decreases | πΆ Source Study | |
Abyssivirga | genus | Increases | πΆ Source Study | |
Abyssivirga | genus | Increases | πΆ Source Study | |
Acetatifactor | genus | Increases | πΆ Source Study | |
Acetatifactor | genus | Increases | πΆ Source Study |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive β X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 1.3 | 1.3 | |
Acne | 5.6 | 3.2 | 0.75 |
Addison's Disease (hypocortisolism) | 0.5 | 0.5 | |
ADHD | 9 | 4.6 | 0.96 |
Age-Related Macular Degeneration and Glaucoma | 0.6 | 0.5 | 0.2 |
Allergic Rhinitis (Hay Fever) | 8.9 | 4.7 | 0.89 |
Allergies | 13.2 | 11.1 | 0.19 |
Allergy to milk products | 6.4 | 3.8 | 0.68 |
Alopecia (Hair Loss) | 2.7 | 2.9 | -0.07 |
Alzheimer's disease | 18.2 | 17.7 | 0.03 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription
All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]